New treatment could be an alternative to gene replacement therapy for choroideremia
Researchers have shown that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia.
New funds for eye research from Fight for Sight and partner charities
Find out what’s in the autumn 2016 awards
Fight for Sight and Sparks partner to fund childhood blindness research
Researchers at the University of Bath are developing a test for a complication of childhood arthritis that affects the eye
Retinitis pigmentosa gene discovery may reveal a new route to inherited blindness
RP Genome Project research discovers 6 faults in the REEP6 gene that affect families in the UK and USA.
Gut microbes can influence the risk of wet AMD
High-fat diet leads to inflammation throughout the body and can prompt unhealthy new blood vessel growth in the eye
Retinal activity in autism, ADHD and Duchenne muscular dystrophy
Fight for Sight and Thomas Pocklington Trust form new partnership to fund vision research
Tackling the causes of inherited blindness that affect adults and children
Fight for Sight and National Eye Research Centre partner to co-fund two new studies
New type of glaucoma treatment in clinical trial
Researchers aim to protect the optic nerve instead of lowering eye pressure
Peek founder wins lifetime achievement award
The award is part of the Clearly campaign for better eye care
Better options for treating birdshot
New research funding partnership between Fight for Sight and Birdshot Uveitis Society
Cell transplant study points to a potential new way to repair the retina
Researchers discover a new type of communication between donor photoreceptors developed from stem cells and host photoreceptors in mice with retinal dystrophy
Human breast milk drops help the cornea to heal from wounds
Researchers think it could become an alternative to existing treatments
Making history with Professor Robert MacLaren
The Ophthalmologist magazine has a great feature on the world’s first robot-assisted eye surgery
Charity funding is paramount to UK research
An AMRC infographic on the impact medical research charities have on the UK research environment.
All eyes on the Nobel Prize
The award-winning researcher's work on cell recycling is vital for understanding sight loss
NICE approve Eylea to treat sight-threatening condition
Aflibercept can now be used as the first choice for NHS treatment in macular oedema due to branch retinal vein occlusion
New and emerging treatments for corneal disorders
NIHR report finds 130 upcoming technologies and procedures
Overview – Drs Imre Lengyel and Alan Stewart on AMD
Dr Lengyel and Dr Stewart give a 2-minute summary of their research into a hallmark sign of age-related macular degeneration
Shortt reports: the view from Ophthalmology Futures Forum 2016
Fight for Sight researcher Dr Alex Shortt's quick video summaries of the meeting between industry and top clinicians on the future of treatments for the eye and sight loss.
Robot surgery restores sight
The PRECEYES system is in use at Oxford’s John Radcliffe Hospital
Treating macular degeneration: Fulbright Fight for Sight Research Award 2016
Dr Shyamanga Borooah takes the 5th annual award from the prestigious USA-UK partnership for eye research
New funds for Scottish research on age-related eye conditions
Fight for Sight teams up with the Scottish government’s Chief Science Office
High eye pressure in glaucoma may be due to an overactive control gene in the drainage system
A common variation in the microRNA gene miR-182 is linked to primary open angle glaucoma
Alcohol abuse drug can be repurposed to treat a blinding disorder
Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis and returns human scarring cells from people with the condition back to normal
Uveitis drug gets approval in Europe
Adalimumab is the first ‘biologic’ drug licensed to treat some types of non-infectious inflammation in the middle part of the eye
Stem cell injection could reduce the risk of sight loss from glaucoma
Researchers in the USA show that the eye’s drainage system can be repaired
An alternative to corneal transplant for a common corneal disorder
Small USA study shows minor surgery improves vision for 3 in 4 treatments
Nerve cell connections regrow and partly restore sight in mice with optic crush injury
A major step forward for optic nerve regeneration research
Google DeepMind partners with Moorfields to help diagnose eye conditions sooner
One million digital eye scans will be analysed using artificial intelligence
Central to vision
Spotlight on research into conditions that affect the macula during Macula Week 2016.
Tackling the cause of sight loss in Usher syndrome
Spotlight on retinitis pigmentosa during Deafblind Awareness Week 2016
Patients think Peek could transform eye health
Healthcare workers and eye service decision-makers also give positive reviews for the smartphone suite
Inflammation and scarring form a positive feedback loop in trachoma
Results from two Fight for PhD students take us closer to developing treatment to prevent blindness from a widespread tropical condition
Overview - Dr Tiarnan Keenan on AMD
Dr Keenan gives a 1-minute summary of his research on a genetic fault that increases the risk of getting age-related macular degeneration.
Fight for Sight PhD students tackle the silent thief of sight
Developing new tests for detecting and monitoring glaucoma and understanding the condition in it rare and most common forms
New inserts will not reverse the symptoms of glaucoma
But the good news is that they may be better at preventing future sight loss than existing glaucoma treatments.
Help us review up-and-coming treatments for corneal disorders
We’re looking for patients, relatives and carers of people with corneal conditions to join a 2-hour focus group in London on 27 May.
Choroideremia gene therapy gives long-term benefit to vision
Encouraging results from a 3.5-year follow up to the Phase I clinical trial
Preventing secondary cataract
A new focus for AMD drug target could reduce the need for millions of follow-up eye operations
Professor Sir Peng Tee Khaw recognised for impact in ophthalmology
World-renowned glaucoma surgeon voted member of The 2016 Power List
Rescuing human light-sensors in a common form of Leber congenital amaurosis
Fight for Sight-funded scientists successfully test new potential treatment for severe inherited childhood sight loss
Help us plan a study to find out about UK eye health
Join the United Kingdom Eye Survey as a lay member of the Board
New sight test detects early AMD
Fight for Sight researchers design an eye chart that could lead to earlier diagnosis for millions of people
Poppers and eye health
A round-up of what we know about a popular ‘drug’ that may be linked to sight loss
Eight new PhD studentships for 2016-19
Fight for Sight has awarded a new round of grants for eye research.
Fats, sugar and energy: a new way to think of treating wet AMD?
Research points to a potentially safer way to stop sight-threatening blood vessels growing in the eye
Measuring eye pressure in glaucoma research using iPerfusion
#WorldGlaucomaWeek: Fight for Sight researchers develop a new tool that could make it easier to develop new treatments
Stem cells regrow the lens and repair the front of the eye
A new cataract surgery technique could mean the end of artificial lenses and researchers take a first step towards growing new eyes
Fighting the silent thief of sight
A World Glaucoma Week round-up of recent advances in glaucoma research from Fight for Sight scientists
High-precision robotic system targets eye surgery
NightstaRx and the University of Oxford team-up with Dutch technology company
Understanding the mechanics of a rare blinding disorder passed from parents to their children
Scientists have identified a key cause of damage to the cornea in Meesmann epithelial corneal dystrophy.
Leading infectious cause of blindness linked to sexually transmitted infection
Chlamydia can exchange genes between sites of infection
Scientists discover genetic changes linked to a major risk factor for blinding trachoma
Aiming to understand why the effects of brief infections are so long-lasting in the world’s leading infectious cause of blindness
Variations in the gene SLC19A3 protect against diabetic retinopathy
Differences in the way the body uses vitamin B1 affect the risk of complications from diabetes
No miracle cure for dry AMD
A look behind the headlines at reports that cholesterol-lowering statins improve vision
Gene editing improves vision in rat retinitis pigmentosa
A 'revolutionary' new tool that’s also showing promise in X-linked RP and corneal dystrophy research.
Breakthrough discovery in the genetics of corneal dystrophies
A step towards treatment that could end the need for transplant surgery
Clinical trials for age-related macular degeneration
Researchers are taking note of the Sight Loss and Vision Priority Setting Partnership
Scientists pinpoint 3 new genes linked to the risk of primary open-angle glaucoma
Results part-funded by Fight for Sight suggest new targets for screening, prevention and treatment.
Rare and common genetic faults that affect the risk of age-related macular degeneration.
New genes discovered in a study that will improve the way future research is done.
Scientists identify variations in the AIPL1 gene that cause Leber congenital amaurosis
The results are a vital step towards gene therapy for a cause of severe sight loss in young children. We co-funded the research together with RP Fighting Blindness.
Exercise could help treat amblyopia
Results in adults with normal vision point to a possible future treatment for adults with 'lazy eye'
Fight for Sight’s research round-up 2015
Spotlight on inherited eye disorders, AMD, glaucoma and corneal blindness
New funds for eye research in our autumn 2015 grants round
Fight for Sight’s Small Grant Award Schemes for 2015 have funded 21 new research projects at a cost of £0.3 million.
Visual stress could be a symptom of ME
Problems looking at patterns might help diagnose the condition also known as chronic fatigue syndrome (CFS)
Low-dose eye drops slow short-sightedness by half in growing children
The treatment could become an important part of preventing sigh loss worldwide
Medical Research Council announces funds for AMD clinical trials
A new approach that might help the people who don't respond to standard treatment.
Parkinson’s drug could treat macular degeneration
A study of millions of health records shows levodopa delays or prevents a major cause of sight loss.
$35 million more to gene therapy for inherited retinal conditions
NightstaRx secures investment from venture capital firm New Enterprise Associates
Something good to say about cholesterol
How close are we to developing a non-surgical treatment for cataract?
Sterol eye drops make cataracts less cloudy
Promising research in animals and human tissue on developing non-surgical treatment.
Gene therapy halts sight loss in dogs with late-stage retinitis pigmentosa
Results from the study suggest treatment can preserve useful vision for at least 2 years.
Recycling in the eye is key to seeing in colour and bright light
A discovery that might one day lead to preventing sight loss from age-related macular degeneration.
Gene therapy researcher wins MRC/Fight for Sight Clinical Training Fellowship award
Dr Harry Orlans will work at the University of Oxford to develop a treatment for dominant retinitis pigmentosa.
Scientists test new gene therapy in Leber hereditary optic neuropathy
The treatment restored vision to mice with the most common genetic fault to cause the condition in humans.
High-tech face furniture
A look at some potential ways to improve vision in AMD and after eye cancer and at new technology to correct refractive error.
Would you and your child like to take part in an exciting research study?
Researchers at Great Ormond Street are studying ‘cerebral visual impairment’.
VISION 2020 UK hosts seminar for funders of eye research
The first ever Funders of Eye Research Summit (FundERS 2015) was created in association with Fight for Sight.
Stem cell surgery aims to give sight back to people with AMD
A 60-year-old woman has become the world’s first person to have an experimental stem cell treatment for age-related macular degeneration.
Research to edit the human genome should go ahead, say leading UK science bodies
A joint statement calls for a broad and inclusive discussion about the future implications.
Hidden lesions predict the risk of sight loss from diabetic retinopathy
New 'wide-field' imaging can see more of the retina and reveal who is most at risk.
2015 Fulbright Fight for Sight Research Award announced
Focus on: diabetic retinopathy
Cataract treatment with eye drops instead of surgery could be coming soon
Promising pre-clinical research shows that lanosterol can turn cloudy lenses clear
What’s on the horizon to treat inherited retinal diseases?
A review of new and emerging technologies highlights some really important concerns that come directly from patients.
Gene therapy gives long-term protection to photoreceptor cells in a mouse model of retinitis pigmentosa
Fight for Sight results published in Molecular Therapy show that the cells could drive visually-guided behaviour, even in late stage disease.
Clean-up cells munch through photoreceptors in retinitis pigmentosa
Microglia could make a new target for treatment to slow sight loss.
Canadian gene therapy trial to treat choroideremia
Biopharmaceutical company Nightstar announces new study at the University of Alberta.
Researchers identify genetic fault that can cause a keyhole shape in the eye
UK and Italian researchers have discovered the genetic cause of a rare form of blindness, in a project co-funded by Fight for Sight.
Fight for Sight is working to prevent sight loss due to diabetes
A look at our diabetic retinopathy research for Diabetes Week.
Nine new research projects funded in our spring 2015 grants round
The projects will take place at top UK institutions in Belfast, London, St Andrews, Edinburgh, Cardiff and Durham.
Faulty ‘housekeeping’ gene causes rare form of complete colour blindness
International research team discovers unexpected role for ATF6 in vision.
Peek eye test app works as well as visual acuity charts
Study shows the Peek Acuity app is as fast and accurate as using standard eye charts.
New form of inherited blindness discovered
RP Genome Project research reveals that the gene DRAM2 is essential for vision.
Short-sightedness on the rise in the young
Young people of European ancestry are more likely to be short-sighted than older generations.
Fight for Sight cataract researcher wins international award
USA’s National Foundation for Eye Research recognises Dr Michael Wormstone's significant scientific work on the lens
A temporary benefit to night vision
Final results from the first clinical trial of gene therapy for Leber congenital amaurosis.
Deadly ‘diet drug’ can also damage your eyes
Dinitrophenol (DNP) linked to serious side-effects including fast-forming cataracts and glaucoma.
Stem cell injection has potential to halt sight loss in early AMD
Results from a pre-clinical study show that a single injection lead to benefits lasting '16 human years'.
New gene for Leber congenital amaurosis
Faults in PNPLA6 lead to the death of light-sensitive cells in the eye.
Different barriers to cell transplant success between the inherited eye conditions
The process of scarring in the retina after photoreceptor loss varies on the genetic fault behind the condition.
Give wet AMD drug early to keep sight for longer
New study finds it's better to start treatment when sight test scores are under 6/12
South-east England ahead on genetic tests for inherited eye conditions
The results are part of Fight for Sight's REGARD programme to build an optimal, patient-led model of care services.
What’s the best way to spot wet AMD early?
A study at hospitals across the UK to compare currently available NHS tests to the 'gold standard' diagnostic test.
Gene therapy for choroideremia gets ‘orphan drug’ status
UK and USA regulators approve the incentive to develop treatments for rare conditions
Seven new PhD studentship awards for 2015
Fight for Sight has awarded seven new PhD studentships in eye research for 2015.
A new source of stem cells for repairing the cornea
Teeth may be a good source of cells to repair the eye and restore sight.
New choroideremia gene therapy clinical trial
Researchers at the University of Pennsylvania are to begin the first US clinical trial of gene therapy for choroideremia
An extra £5 million for gene therapy start up
Syncona LLP increases its investment in independent pharmaceutical Nightstar to £17 million
Eye health could help diagnose people with chronic fatigue syndrome
We partner with Thomas Pocklington Trust to co-fund research into a little-known aspect of this disabling, long-term condition.
Calcium in the back of the eye may be a trigger for AMD
A mineral found in teeth and bones is identified in the macula for the first time.
Can 3D facial imaging help manage a disfiguring cause of sight loss?
Fight for Sight and British Thyroid Foundation partner to co-fund new research
Smartphone eye examination app Peek Retina goes for crowdfunding
Indiegogo appeal to raise extra funds for Peek to be manufactured and delivered globally
‘No water’ campaign warns of a sight-threatening infection
Contact lens manufacturer adds 'No water’ campaign message to their packaging to raise awareness of Acanthamoeba keratitis – a serious, sight-threatening eye infection.
Eye disorders identified by how we watch TV
Fight for Sight researchers publish proof-of-principle study that could lead to new tests for glaucoma and other sight loss conditions.